The American Telemedicine Association® (ATA) is celebrating the 3rd annual Telehealth Awareness Week®, taking place September 17-23, 2023. This week highlights the value telehealth brings to patients and helps to expand access to quality care, how virtual care is addressing many of the challenges faced by healthcare providers, and its role in building a modern, omnichannel care delivery system.
Telehealth Awareness Week will feature a diverse coalition of stakeholders including hospital systems and medical practices, professional associations and patient advocacy leaders, policymakers, telehealth solution providers, and others.
DoseSpot Celebrates Telehealth
At DoseSpot, we are proud to work with a variety of innovators in the Telehealth industry who go above and beyond to deliver best-in-class care. Our solution powers care delivery from anywhere so that telehealth prescribers can meet their patients where they are.
This week we are celebrating the great work and impact the telehealth industry has made on care delivery.
DEA Timeline of Telemedicine Flexibilities
DEA Public Listening Sessions on Telemedicine Regulations
DEA Hosts Public Listening Sessions on Telemedicine Regulations –MEDIA ADVISORY
The DEA will be hosting listening sessions to receive additional input concerning the practice of telemedicine with regards to controlled substances.
…
DEA Temporarily Extends Telemedicine Flexibilities for the Prescribing of Controlled Substances
Throughout the COVID-19 pandemic, the Drug Enforcement Administration (DEA) granted providers the flexibility to prescribe clinically appropriate controlled substance medications without requiring an in-person visit, which was particularly crucial amidst the global shutdown. However, this allowance was contingent upon the Public Health Emergency (PHE) declared by the U.S. Health and Human Services (HHS) Secretary being in effect and was scheduled to be rescinded when it ended on May 11, 2023. With one day to spare on May 10, the DEA and the Substance Abuse and Mental Health Services Administration (SAMHSA) released a temporary rule extending the pandemic prescribing flexibility until November 11, 2023.